These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 690034)

  • 21. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 22. Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine.
    Perkins RL; Carlisle HN; Saslaw S
    Am J Med Sci; 1968 Aug; 256(2):122-9. PubMed ID: 5672745
    [No Abstract]   [Full Text] [Related]  

  • 23. Contribution to the pharmacokinetics of a new cephalosporin derivative.
    Dvorácek K; Modr Z; Schmidt O; Necásková A
    Arzneimittelforschung; 1974 Sep; 24(9b):1468-70. PubMed ID: 4479805
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the bioequivalence of second generation cephalosporins: cefaclor capsules and suspension.
    Koytchev R; Ozalp Y; Erenmemisoglu A; Tyutyulkova N; Gatchev E; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):583-7. PubMed ID: 15497664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detemination of cephalexin in serum, urine, bile, peritoneal exudate and bone marrow].
    Irmer W; Lubach D; Sucker U
    Dtsch Med Wochenschr; 1971 Mar; 96(11):464-8. PubMed ID: 5548186
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacokinetics and metabolism of the cephalosporins].
    Graninger W
    Wien Klin Wochenschr Suppl; 1983; 142():11-5. PubMed ID: 6580781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.
    Balant L; Dayer P; Rudhardt M; Allaz AF; Fabre J
    Clin Ther; 1980; 3(Spec Issue):50-9. PubMed ID: 6446399
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cephazoline: evolution of serum levels following the extent of renal functional disturbance. Comparison with other cephalosporins].
    Duval J; Lagrue G; Soussy CJ; Debain P
    Nouv Presse Med; 1974 Apr; 3(0):20-22. PubMed ID: 4837111
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacology of oral cephradine.
    Zaki A; Schreiber EC; Weliky I; Knill JR; Hubsher JA
    J Clin Pharmacol; 1974; 14(2):118-26. PubMed ID: 4591487
    [No Abstract]   [Full Text] [Related]  

  • 30. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cephalexin in serum, dialysate and urine of patients with renal diseases].
    Ritzerfeld W; Westerboer S; Trappe H
    Arzneimittelforschung; 1970 Dec; 20(12):1881-4. PubMed ID: 5537088
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefadroxil kinetics in patients with renal insufficiency.
    Cutler RE; Blair AD; Kelly MR
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):514-21. PubMed ID: 436355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of therapeutic activity, of the secondary effects of blood and urinary levels of cephaloglycin by oral administration].
    Escárzaga Tapia E; Luna Castro M; González Díaz S; Gutiérrez Dávila M; Horta Sánchez C; Lozada L
    Rev Invest Clin; 1969; 21(1):35-47. PubMed ID: 5386523
    [No Abstract]   [Full Text] [Related]  

  • 35. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
    Reutter F; Maurice NP
    Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
    [No Abstract]   [Full Text] [Related]  

  • 37. [Kidney lymph concentration of cephalosporin derivatives. Experimental studies in the dog].
    Naber K; Sauerwein D; Weidemann H; Heinmöller G
    Adv Clin Pharmacol; 1974; 8():111-7. PubMed ID: 4468725
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cephalexin, a new oral cephalosporin. Results of a study on human pharmacology].
    Brogard JM; Kuntzmann F; Lavillaureix J; Stahl J
    Therapeutique; 1970 Mar; 46(3):315-23. PubMed ID: 5422201
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of five cephalosporins in healthy male volunteers.
    Paradelis AG; Stathopoulos G; Trianthaphyllidis C; Logaras G
    Arzneimittelforschung; 1977; 27(11):2167-70. PubMed ID: 580023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.